281191-63-7

Basic information

• Product Name: (1'R,2'R,3'S,4'R,5'S)-4-(2,6-dichloropurin-9-yl)-1-[(phenylmethoxy)methyl]bicyclo[3.1.0]hexane-2,3-(O-isopropylidene)
• Synonyms: (1'R,2'R,3'S,4'R,5'S)-4-(2,6-dichloropurin-9-yl)-1-[(phenylmethoxy)methyl]bicyclo[3.1.0]hexane-2,3-(O-isopropylidene)
• CAS NO: 281191-63-7
• Molecular Weight: 461.348
• Mol File: 281191-63-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (1'R,2'R,3'S,4'R,5'S)-4-(2,6-dichloropurin-9-yl)-1-[(phenylmethoxy)methyl]bicyclo[3.1.0]hexane-2,3-(O-isopropylidene)(CAS DataBase Reference)
• NIST Chemistry Reference: (1'R,2'R,3'S,4'R,5'S)-4-(2,6-dichloropurin-9-yl)-1-[(phenylmethoxy)methyl]bicyclo[3.1.0]hexane-2,3-(O-isopropylidene)(281191-63-7)
• EPA Substance Registry System: (1'R,2'R,3'S,4'R,5'S)-4-(2,6-dichloropurin-9-yl)-1-[(phenylmethoxy)methyl]bicyclo[3.1.0]hexane-2,3-(O-isopropylidene)(281191-63-7)

Safety Data

• Hazardous Substances Data: 281191-63-7(Hazardous Substances Data)

Upstream product

• 5451-40-1 2,6 dichloropurine 
• 156126-13-5 (1aR,1bR,4aS,5S,5aS)-1a-Benzyloxymethyl-3,3-dimethyl-hexahydro-2,4-dioxa-cyclopropa[a]pentalen-5-ol 

Downstream Products

• 436847-21-1 (1'S,2'R,3'S,4'R,5'S)-4-(6-amino-2-chloro-9H-purin-9-yl)-1-[(phenylmethoxy)methyl]bicyclo[3.1.0]hexane-2,3-(O-isopropylidene) 
• 281191-59-1 MRS 1760 
• 352552-17-1 (1aS,1bR,4aS,5R,5aS)-5-[2-Chloro-6-(3-iodo-benzylamino)-purin-9-yl]-3,3-dimethyl-tetrahydro-2,4-dioxa-cyclopropa[a]pentalene-1a-carboxylic acid 
• 436847-13-1 MRS 2339 
• 436847-22-2 (1'S,2'R,3'S,4'R,5'S)-4-(6-methylamino-2-chloro-9H-purin-9-yl)-1-[(phenylmethoxy)methyl]bicyclo[3.1.0]hexane-2,3-(O-isopropylidene) 
• 281191-64-8 (1'R,2'R,3'S,4'R,5'S)-4-[2-chloro-6-(cyclopentylamino)purin-9-yl]-1-[(phenylmethoxy)methyl]bicyclo[3.1.0]hexane-2,3-(O-isopropylidene) 
• 281191-66-0 (1'R,2'R,3'S,4'R,5'S)-4-{2-chloro-6-[(3-iodophenylmethyl)amino]purin-9-yl}-1-[(phenylmethoxy)methyl]bicyclo[3.1.0]hexane-2,3-(O-isopropylidene) 

Relevant articles and documents

Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists

Adenosine receptor agonists have cardioprotective, cerebroprotective, and antiinflammatory properties. We report that a carbocyclic modification of the ribose moiety incorporating ring constraints is a general approach for the design of A1 and